The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

PD-L1 methylation can predict survival in AML patients

Mar 10, 2017

In Acute Myeloid Leukemia (AML), the Programmed Death-1 (PD-1) pathway is hijacked by leukemic cells to facilitate immune evasion which can lead to poor outcomes in patients. AML cells upregulate their expression of Programmed Death Ligand 1 and 2 (PD-L1/PD-L2) thus leading to an inhibition of effector T-cell function via the PD-1 pathway. There is a paucity of data on the epigenetic regulation of PD-1/PD-L1 axis and the mechanism of promoter methylation of PD-L1( CD274) and PD-L2in AML has not been elucidated yet.

In a Letterto the Editor of Leukemia, Diane Goltzand colleagues from the University Hospital Bonn, Germany, investigated  whether there is any association between PD-L1/ PD-L2mRNA expression in AML and promoter methylation (m PD-L1/m PD-L2).

In this study, gene methylation and mRNA data were obtained from AML patient (n =197) diagnostic samples generated by the TCGA Research Network.

The key results of the study were:

  • Promoter methylation inversely correlated with the mRNA expression of PD-L1(r = -0.458, P< 0.001) and PD-L2(r = -0.408, P< 0.001)
  • Prolonged Overall Survival (OS [HR = 0.59, P= 0.003]), Event Free Survival (EFS [HR = 0.64 P= 0.011]) and reduced risk of relapse were associated with high m PD-L1methylation

In summary, promoter methylation of PD-L1can predict the survival outcomes of AML patients. The authors concluded by suggesting that PD-L1methylation should be “considered as a companion biomarker” and should be analyzed in current clinical trials with PD-L1/PD-1 blockage in AML patients.

  1. Goltz D. et al. PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia. Leukemia. 2017 Mar; 31(3): 738–743. DOI: 1038/leu.2016.328. [Epub 2016 Nov 14].
More about...

Newsletter

Subscribe to get the best content related to AML delivered to your inbox every month